Literature DB >> 23494016

Is treatment with a high flow nasal cannula effective in acute viral bronchiolitis? A physiologic study.

Christophe Milési1, Julien Baleine, Stefan Matecki, Sabine Durand, Clémentine Combes, Aline Rideau Batista Novais, Gilles Cambonie, Gilles Combonie.   

Abstract

PURPOSE: The high flow nasal cannula (HFNC) has recently been proposed to support infants with respiratory syncytial virus (RSV)-related respiratory distress. However, in this disease, no physiologic data are currently available on the effects of this device. We assessed the capacity of HFNC to generate positive airway pressure, as well as the resulting effects on breathing pattern and respiratory effort.
METHODS: Twenty-one infants less than 6 months old with acute RSV bronchiolitis were studied prospectively in the pediatric intensive care unit of a university hospital. Pharyngeal pressure (PP) and esophageal pressure (Pes) were measured simultaneously at four increasing flows of 1, 4, 6 and 7 L/min delivered through HFNC.
RESULTS: The PP was correlated with flow rate (r = 0.65, p ≤ 0.0001), reaching mean and end-expiratory values of, respectively, 4 (95% CI 3-5) cmH₂O and 6.5 (95% CI 5-8) cmH2O at 7 L/min. A flow ≥2 L/kg/min was associated with the generation of a mean pharyngeal pressure ≥4 cmH₂O with a sensitivity of 67 %, a specificity of 96 %, a positive predictive value of 75 %, and a negative predictive value of 94.5%. Only flows ≥6 L/min provided positive PP throughout the respiratory cycle. From baseline to maximal flow rate, breathing frequency (p < 0.01), T i/T tot (p < 0.05), Pes swing (p < 0.05) and PTPesinsp/min (p < 0.01), an index of respiratory effort, were reduced.
CONCLUSIONS: HFNC with a flow rate equal to or above 2 L/kg/min generated a clinically relevant PP, with improved breathing pattern and rapid unloading of respiratory muscles, in young infants with acute RSV bronchiolitis.

Entities:  

Mesh:

Year:  2013        PMID: 23494016     DOI: 10.1007/s00134-013-2879-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

1.  Noise levels within the ear and post-nasal space in neonates in intensive care.

Authors:  S S Surenthiran; K Wilbraham; J May; T Chant; A J B Emmerson; V E Newton
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-07       Impact factor: 5.747

Review 2.  Research in high flow therapy: mechanisms of action.

Authors:  Kevin Dysart; Thomas L Miller; Marla R Wolfson; Thomas H Shaffer
Journal:  Respir Med       Date:  2009-05-21       Impact factor: 3.415

3.  Observational study of humidified high-flow nasal cannula compared with nasal continuous positive airway pressure.

Authors:  Andrea L Lampland; Brenda Plumm; Patricia A Meyers; Cathy T Worwa; Mark C Mammel
Journal:  J Pediatr       Date:  2008-08-30       Impact factor: 4.406

4.  Chest wall mechanics and respiratory muscles in infants.

Authors:  N L Muller; A C Bryan
Journal:  Pediatr Clin North Am       Date:  1979-08       Impact factor: 3.278

5.  Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery.

Authors:  A Schibler; T M T Pham; K R Dunster; K Foster; A Barlow; K Gibbons; J L Hough
Journal:  Intensive Care Med       Date:  2011-03-03       Impact factor: 17.440

6.  Effects of flow rate and airleak at the nares and mouth opening on positive distending pressure delivery using commercially available high-flow nasal cannula systems: a lung model study.

Authors:  Rashed A Hasan; Robert H Habib
Journal:  Pediatr Crit Care Med       Date:  2011-01       Impact factor: 3.624

7.  Optimal level of nasal continuous positive airway pressure in severe viral bronchiolitis.

Authors:  Sandrine Essouri; Philippe Durand; Laurent Chevret; Laurent Balu; Denis Devictor; Brigitte Fauroux; Pierre Tissières
Journal:  Intensive Care Med       Date:  2011-10-13       Impact factor: 17.440

8.  Non-invasive ventilation as primary ventilatory support for infants with severe bronchiolitis.

Authors:  Etienne Javouhey; Audrey Barats; Nathalie Richard; Didier Stamm; Daniel Floret
Journal:  Intensive Care Med       Date:  2008-05-24       Impact factor: 17.440

Review 9.  Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.

Authors:  Robert C Welliver
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

10.  Randomised controlled trial of nasal continuous positive airways pressure (CPAP) in bronchiolitis.

Authors:  Lena P Thia; Sheila A McKenzie; Tom P Blyth; Caro C Minasian; Wanda J Kozlowska; Siobhan B Carr
Journal:  Arch Dis Child       Date:  2007-03-07       Impact factor: 3.791

View more
  38 in total

1.  High flow on the rise-pediatric perspectives on the FLORALI trial.

Authors:  Christophe Milési; Julien Baleine; Julia le Bouhellec; Marti Pons-Odena; Gilles Cambonie
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

2.  Derivation and Validation of an Objective Effort of Breathing Score in Critically Ill Children.

Authors:  Steven L Shein; Justin Hotz; Robinder G Khemani
Journal:  Pediatr Crit Care Med       Date:  2019-01       Impact factor: 3.624

Review 3.  High-flow nasal cannula therapy for respiratory support in children.

Authors:  Sara Mayfield; Jacqueline Jauncey-Cooke; Judith L Hough; Andreas Schibler; Kristen Gibbons; Fiona Bogossian
Journal:  Cochrane Database Syst Rev       Date:  2014-03-07

4.  High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine is underway to define target populations and optimal flows.

Authors:  Gilles Cambonie; Marti Pons-Odena; Julien Baleine; Christophe Milési
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

5.  High flow nasal cannula (HFNC) versus nasal continuous positive airway pressure (nCPAP) for the initial respiratory management of acute viral bronchiolitis in young infants: a multicenter randomized controlled trial (TRAMONTANE study).

Authors:  Christophe Milési; Sandrine Essouri; Robin Pouyau; Jean-Michel Liet; Mickael Afanetti; Aurélie Portefaix; Julien Baleine; Sabine Durand; Clémentine Combes; Aymeric Douillard; Gilles Cambonie
Journal:  Intensive Care Med       Date:  2017-01-26       Impact factor: 17.440

6.  Comparison of a high-flow humidified nasal cannula to nasal continuous positive airway pressure in children with acute bronchiolitis: experience in a pediatric intensive care unit.

Authors:  Prune Metge; Céline Grimaldi; Sophie Hassid; Laurent Thomachot; Anderson Loundou; Claude Martin; Fabrice Michel
Journal:  Eur J Pediatr       Date:  2014-02-14       Impact factor: 3.183

7.  Use of high-flow nasal cannula in infants with viral bronchiolitis outside pediatric intensive care units.

Authors:  Mélanie Panciatici; Candice Fabre; Sophie Tardieu; Emilie Sauvaget; Marion Dequin; Nathalie Stremler-Le Bel; Emmanuelle Bosdure; Jean-Christophe Dubus
Journal:  Eur J Pediatr       Date:  2019-08-01       Impact factor: 3.183

8.  A multicenter randomized controlled trial of a 3-L/kg/min versus 2-L/kg/min high-flow nasal cannula flow rate in young infants with severe viral bronchiolitis (TRAMONTANE 2).

Authors:  Christophe Milési; Anne-Florence Pierre; Anna Deho; Robin Pouyau; Jean-Michel Liet; Camille Guillot; Anne-Sophie Guilbert; Jérôme Rambaud; Astrid Millet; Mickael Afanetti; Julie Guichoux; Mathieu Genuini; Thierry Mansir; Jean Bergounioux; Fabrice Michel; Marie-Odile Marcoux; Julien Baleine; Sabine Durand; Philippe Durand; Stéphane Dauger; Etienne Javouhey; Stéphane Leteurtre; Olivier Brissaud; Sylvain Renolleau; Aurélie Portefaix; Aymeric Douillard; Gilles Cambonie
Journal:  Intensive Care Med       Date:  2018-10-21       Impact factor: 17.440

9.  High-flow nasal cannula (HFNC) support in interhospital transport of critically ill children.

Authors:  Luregn J Schlapbach; Jonas Schaefer; Ann-Maree Brady; Sara Mayfield; Andreas Schibler
Journal:  Intensive Care Med       Date:  2014-02-15       Impact factor: 17.440

10.  High-flow nasal cannula implementation has not reduced intubation rates for bronchiolitis in Canada.

Authors:  Hilarie Garland; Anna C Gunz; Michael R Miller; Rodrick K Lim
Journal:  Paediatr Child Health       Date:  2020-04-15       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.